CLDXCelldex Therapeutics, Inc.

$2B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+52.8% YoY

Gross Profit

$1M26.8% margin

Operating Income

-$130M-2363.9% margin

Net Income

-$127M-2321.1% margin

EPS (Diluted)

$-19.66

Cash Flow

Operating Cash Flow

-$99M

Free Cash Flow

-$104M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$338M

Total Liabilities

$47M

Stockholders' Equity

$290M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$4M	+52.8%
Gross Profit	$1M	$185,000	+694.1%
Operating Income	-$130M	-$122M	-5.8%
Net Income	-$127M	-$118M	-7.7%

CLDX FY 2015 Earnings — Celldex Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena